ID   AZPB2_ASPTN             Reviewed;        2737 AA.
AC   Q0CF73;
DT   17-JUN-2020, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 1.
DT   10-FEB-2021, entry version 98.
DE   RecName: Full=Non-reducing polyketide synthase ATEG_07661 {ECO:0000303|PubMed:31908094};
DE            Short=NR-PKS {ECO:0000303|PubMed:31908094};
DE            EC=2.3.1.- {ECO:0000305|PubMed:31908094};
DE   AltName: Full=Azasperpyranone A biosynthesis cluster B protein ATEG_07661 {ECO:0000303|PubMed:31908094};
GN   ORFNames=ATEG_07661;
OS   Aspergillus terreus (strain NIH 2624 / FGSC A1156).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;
OC   Aspergillus subgen. Circumdati.
OX   NCBI_TaxID=341663;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=NIH 2624 / FGSC A1156;
RA   Birren B.W., Lander E.S., Galagan J.E., Nusbaum C., Devon K., Henn M.,
RA   Ma L.-J., Jaffe D.B., Butler J., Alvarez P., Gnerre S., Grabherr M.,
RA   Kleber M., Mauceli E.W., Brockman W., Rounsley S., Young S.K., LaButti K.,
RA   Pushparaj V., DeCaprio D., Crawford M., Koehrsen M., Engels R.,
RA   Montgomery P., Pearson M., Howarth C., Larson L., Luoma S., White J.,
RA   Alvarado L., Kodira C.D., Zeng Q., Oleary S., Yandava C., Denning D.W.,
RA   Nierman W.C., Milne T., Madden K.;
RT   "Annotation of the Aspergillus terreus NIH2624 genome.";
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=23621425; DOI=10.1021/ja401945a;
RA   Chiang Y.M., Oakley C.E., Ahuja M., Entwistle R., Schultz A., Chang S.L.,
RA   Sung C.T., Wang C.C., Oakley B.R.;
RT   "An efficient system for heterologous expression of secondary metabolite
RT   genes in Aspergillus nidulans.";
RL   J. Am. Chem. Soc. 135:7720-7731(2013).
RN   [3]
RP   FUNCTION.
RX   PubMed=24412543; DOI=10.1016/j.chembiol.2013.12.005;
RA   Wang M., Beissner M., Zhao H.;
RT   "Aryl-aldehyde formation in fungal polyketides: discovery and
RT   characterization of a distinct biosynthetic mechanism.";
RL   Chem. Biol. 21:257-263(2014).
RN   [4]
RP   FUNCTION, INDUCTION, DISRUPTION PHENOTYPE, PATHWAY, AND BIOTECHNOLOGY.
RX   PubMed=31908094; DOI=10.1002/anie.201915514;
RA   Huang X., Zhang W., Tang S., Wei S., Lu X.;
RT   "Collaborative biosynthesis of a class of bioactive azaphilones by two
RT   separate gene clusters containing four PKS/NRPSs with transcriptional
RT   cosstalk in fungi.";
RL   Angew. Chem. Int. Ed. 0:0-0(2020).
CC   -!- FUNCTION: Non-reducing polyketide synthase; part of the cluster B that
CC       mediates the biosynthesis of azasperpyranones, members of the
CC       azaphilone family that exhibit anti-cancer activities
CC       (PubMed:31908094). Azasperpyranones are synthesized by 2 clusters, A
CC       and B (PubMed:31908094). Cluster A is responsible for the production of
CC       the polyhydric phenol moiety while the azaphilonoid scaffold is
CC       produced by the cluster B (PubMed:31908094). The non-reducing
CC       polyketide synthase ATEG_03629 produces 5-methyl orsellinic acid, which
CC       is then reduced to 5-methyl orsellinic aldehyde by the NRPS-like
CC       protein ATEG_03630 (PubMed:24412543). 5-methyl orsellinic aldehyde is
CC       then first hydroxylated by the FAD-dependent monooxygenase ATEG_03635
CC       and subsequently hydroxylated by the cytochrome P450 monooxygenase
CC       ATEG_03631 to produce the unstable polyhydric phenol precursor of
CC       azasperpyranones (PubMed:31908094). On the other hand, the polyketide
CC       synthase ATEG_07659 is responsible for producing the 3,5-
CC       dimethyloctadienone moiety from acetyl-CoA, three malonyl-CoA, and two
CC       S-adenosyl methionines (SAM) (Probable). The 3,5-dimethyloctadienone
CC       moiety is then loaded onto the SAT domain of ATEG_07661 and extended
CC       with four malonyl-CoA and one SAM, which leads to the formation of 2,4-
CC       dihydroxy-6-(5,7-dimethyl-2-oxo-trans-3-trans-5-nonadienyl)-3-
CC       methylbenzaldehyde (compound 8) after reductive release and aldol
CC       condensation (Probable). The FAD-dependent monooxygenase ATEG_07662 is
CC       the next enzyme in the biosynthesis sequence and hydroxylates the side
CC       chain at the benzylic position of compound 8 (Probable). In Aspergillus
CC       nidulans, afoF, the ortholog of the FAD-dependent oxygenase ATEG_07660,
CC       is the key enzyme for the biosynthesis of asperfuranone by catalyzing
CC       the hydroxylation at C-8 of to prevent the formation of a six-membered
CC       ring hemiacetal intermediate and thus facilitatings the formation of a
CC       five-membered ring to produce asperfuranone (Probable). In Aspergillus
CC       terreus, ATEG_07660 is probably not functional, which leads to the
CC       formation of the six-membered ring hemiacetal intermediate
CC       presperpyranone instead of asperfuranone (Probable). Finally,
CC       ATEG_03636 is involved in the condensation of the polyhydric phenol
CC       moiety produced by cluster A and the perasperpyranone precursor
CC       produced by cluster B, to yield azasperpyranone A (Probable). Further
CC       modifications of azasperpyranone A result in the production of
CC       derivatives, including azasperpyranone B to F (PubMed:31908094).
CC       {ECO:0000269|PubMed:24412543, ECO:0000269|PubMed:31908094,
CC       ECO:0000305|PubMed:31908094}.
CC   -!- PATHWAY: Secondary metabolite biosynthesis.
CC       {ECO:0000269|PubMed:31908094}.
CC   -!- INDUCTION: Expression is induced by the azasperpyranone cluster A-
CC       specific transcription factor ATEG_07666 which is itself regulated by
CC       the azasperpyranone transcriptional regulator ATEG_07667.
CC       {ECO:0000269|PubMed:31908094}.
CC   -!- DOMAIN: Multidomain protein; including an N-terminal starter unit:ACP
CC       transacylase (SAT) domain, a beta-ketoacyl synthase (KS) domain, a
CC       malonyl-CoA:ACP transacylase (MAT) domain, a product template domain, a
CC       acyl carrier protein (ACP) domain, a methyltransferase domain and a
CC       reductive NADPH-binding domain that is required for NADPH-dependent
CC       product release. {ECO:0000305|PubMed:31908094}.
CC   -!- DOMAIN: Multidomain protein; including a starter unit:ACP transacylase
CC       (SAT) that selects the starter unit; a ketosynthase (KS) that catalyzes
CC       repeated decarboxylative condensation to elongate the polyketide
CC       backbone; a malonyl-CoA:ACP transacylase (MAT) that selects and
CC       transfers the extender unit malonyl-CoA; a product template (PT) domain
CC       that controls the immediate cyclization regioselectivity of the
CC       reactive polyketide backbone; a methyltransferase domain; a reductive
CC       NADPH-binding domain that is required for NADPH-dependent product
CC       release; and an acyl-carrier protein (ACP) that serves as the tether of
CC       the growing and completed polyketide via its phosphopantetheinyl arm.
CC       {ECO:0000305|PubMed:31908094}.
CC   -!- DISRUPTION PHENOTYPE: Abolishes the production of azasperpyranone
CC       A(AZA-A). {ECO:0000269|PubMed:31908094}.
CC   -!- BIOTECHNOLOGY: Azasperpyranones display potential anti-cancer
CC       activities (PubMed:31908094). Azasperpyranones A, C, D, and F exhibit
CC       potent growth-inhibitory activity against the A549, HepG2, HCT-116, and
CC       HL-60 cell lines, with IC(50) values of 2.39-14.42 mm, respectively
CC       (PubMed:31908094). Moreover, azasperpyranone D significantly inhibits
CC       HCT-116 xenograft tumor growth in BALB/c-nu mice (PubMed:31908094). In
CC       addition, azasperpyranones A and C can bind with four kinds of
CC       therapeutic targets for cancer, eEF2K, FGFR, survivin, and TNF-a
CC       (PubMed:31908094). {ECO:0000269|PubMed:31908094}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH476604; EAU31923.1; -; Genomic_DNA.
DR   RefSeq; XP_001216282.1; XM_001216282.1.
DR   SMR; Q0CF73; -.
DR   STRING; 33178.CADATEAP00001525; -.
DR   EnsemblFungi; EAU31923; EAU31923; ATEG_07661.
DR   GeneID; 4323014; -.
DR   VEuPathDB; FungiDB:ATEG_07661; -.
DR   eggNOG; KOG1178; Eukaryota.
DR   eggNOG; KOG1202; Eukaryota.
DR   HOGENOM; CLU_000022_6_2_1; -.
DR   OMA; WHVYARH; -.
DR   OrthoDB; 13314at2759; -.
DR   Proteomes; UP000007963; Unassembled WGS sequence.
DR   GO; GO:0004315; F:3-oxoacyl-[acyl-carrier-protein] synthase activity; IEA:InterPro.
DR   GO; GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IEA:InterPro.
DR   GO; GO:0032259; P:methylation; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.1200.10; -; 1.
DR   Gene3D; 3.10.129.110; -; 1.
DR   Gene3D; 3.40.366.10; -; 1.
DR   Gene3D; 3.40.47.10; -; 1.
DR   InterPro; IPR001227; Ac_transferase_dom_sf.
DR   InterPro; IPR036736; ACP-like_sf.
DR   InterPro; IPR014043; Acyl_transferase.
DR   InterPro; IPR016035; Acyl_Trfase/lysoPLipase.
DR   InterPro; IPR013120; Far_NAD-bd.
DR   InterPro; IPR041068; HTH_51.
DR   InterPro; IPR018201; Ketoacyl_synth_AS.
DR   InterPro; IPR014031; Ketoacyl_synth_C.
DR   InterPro; IPR014030; Ketoacyl_synth_N.
DR   InterPro; IPR016036; Malonyl_transacylase_ACP-bd.
DR   InterPro; IPR013217; Methyltransf_12.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR020841; PKS_Beta-ketoAc_synthase_dom.
DR   InterPro; IPR020807; PKS_dehydratase.
DR   InterPro; IPR042104; PKS_dehydratase_sf.
DR   InterPro; IPR020806; PKS_PP-bd.
DR   InterPro; IPR009081; PP-bd_ACP.
DR   InterPro; IPR006162; Ppantetheine_attach_site.
DR   InterPro; IPR029063; SAM-dependent_MTases.
DR   InterPro; IPR032088; SAT.
DR   InterPro; IPR016039; Thiolase-like.
DR   Pfam; PF00698; Acyl_transf_1; 1.
DR   Pfam; PF18558; HTH_51; 1.
DR   Pfam; PF00109; ketoacyl-synt; 1.
DR   Pfam; PF02801; Ketoacyl-synt_C; 1.
DR   Pfam; PF08242; Methyltransf_12; 1.
DR   Pfam; PF07993; NAD_binding_4; 1.
DR   Pfam; PF00550; PP-binding; 1.
DR   Pfam; PF14765; PS-DH; 1.
DR   Pfam; PF16073; SAT; 1.
DR   SMART; SM00827; PKS_AT; 1.
DR   SMART; SM00825; PKS_KS; 1.
DR   SMART; SM00823; PKS_PP; 1.
DR   SUPFAM; SSF47336; SSF47336; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   SUPFAM; SSF52151; SSF52151; 1.
DR   SUPFAM; SSF53335; SSF53335; 1.
DR   SUPFAM; SSF53901; SSF53901; 1.
DR   SUPFAM; SSF55048; SSF55048; 1.
DR   PROSITE; PS00606; B_KETOACYL_SYNTHASE; 1.
DR   PROSITE; PS50075; CARRIER; 1.
DR   PROSITE; PS00012; PHOSPHOPANTETHEINE; 1.
PE   1: Evidence at protein level;
KW   Acyltransferase; Methyltransferase; Multifunctional enzyme; NADP;
KW   Phosphopantetheine; Phosphoprotein; Reference proteome; Transferase.
FT   CHAIN           1..2737
FT                   /note="Non-reducing polyketide synthase ATEG_07661"
FT                   /id="PRO_0000450085"
FT   DOMAIN          1750..1824
FT                   /note="Carrier"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   REGION          75..245
FT                   /note="N-terminal acylcarrier protein transacylase domain
FT                   (SAT)"
FT                   /evidence="ECO:0000255"
FT   REGION          430..857
FT                   /note="Ketosynthase (KS) domain"
FT                   /evidence="ECO:0000255"
FT   REGION          969..1260
FT                   /note="Malonyl-CoA:ACP transacylase (MAT)"
FT                   /evidence="ECO:0000255"
FT   REGION          1399..1681
FT                   /note="Product template (PT) domain"
FT                   /evidence="ECO:0000255"
FT   REGION          2094..2270
FT                   /note="Methyltransferase domain"
FT                   /evidence="ECO:0000255"
FT   REGION          2362..2665
FT                   /note="NADPH-binding domain"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        154
FT                   /note="Nucleophile; for transacylase activity"
FT                   /evidence="ECO:0000250|UniProtKB:A0A0K0MCJ4"
FT   ACT_SITE        276
FT                   /note="Proton donor/acceptor; for transacylase activity"
FT                   /evidence="ECO:0000250|UniProtKB:A0A0K0MCJ4"
FT   ACT_SITE        603
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10022"
FT   MOD_RES         1784
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
SQ   SEQUENCE   2737 AA;  299142 MW;  DFE1562184AB5723 CRC64;
     MTHTTGPTKA SGESTIFLFG PHVGTFTKQS MNKLVHPLSQ SPQRDWILDT IAELPGYWDA
     LAAKMPDVAR DIDGSRSLAE LDSWLRHGSA NLGEDDSNLP SIIVGPLVVF IQLTQYWRHL
     ELTKAGTQAT DLQADLVAMH SNQTGDKVEI LGFCAGLLAA LAVASSNNRQ EFQKYGAVAV
     RLAMLIGALI DAQEVWDKAS GKGSSSSYAV AWRGPKQEED MTRIIDDLAA NAYIAVRYDQ
     TRATVTASET IAPLLLKRFR AAGITVAEVG IKGQIHSPNP DRRAHTNALV DLCNSLPGLQ
     YAAAERLALQ TYDNQGDGKP LLPDRGSLTE MVLRSILVQQ CHWYDTFSAV TERHQDPYVV
     TFGLERCVPP TLMRSLGGRQ VFFEDLPKDP SHPSSWMPNA PHGPQQQLQQ RQLPVEVHTK
     PAFDVSNEAI AIVGMSVKTA GADDLAEFAE MLKTGQSQHI PITRDRLMHD MLFRESADSD
     PKRKYYGCFF RDGDAFDHKF FKRSPREAAA MDPQSRIVLQ TAYQAIEQSG YFAEDHTGYT
     PDGRDKAHVG VYLGSCGVDY EHNISCHDPN AFTATGALKS FITGRVSHLF GWTGPCMTFD
     TACSSSAVAI HTACRNLLSG ECTAALAGGS NTVTNMNWFQ NLAAGSFVSP TGQCKPFDDD
     ADGYCRAEGA AFVFLKRLSD AVRDGNPILA TIASSAVYQN QNCTPLFVPN SPSLSHLFKD
     VMHQAKITAN DVSLVEAHGT GTPVGDPAEY ESIRVALGGP IRKKTLPIGS VKGHIGHTEG
     ASGAIALVKI IMMMREGFIP PQASFKKMNR KIPVRADDNM EVVTKLRPWD EPHKTALLNN
     YGACGSNASM IITEPDKALS GPIDGSRYRN TGQRYPFWIP GFDSRAITAY CAKLGSWLRS
     CRQEPTLADV SFNVNRQSNR SLTQGFIFNC RSMTELHEKL EQAAAAGKDA AANAGITPVK
     AERPVVLCFG GQVSRFVGLD RNLFESVAIL RQHLDHVDAV VTSQGLGSIY PEIFEREPVR
     DTVKLQTMLF ALQYACAKSW MDSGLQGKVQ AVVGHSFGEI TALCIAGVLS LEHTVQLVAA
     RAALVRDNWG ADPGAMMAIE ADENLVNELL LEANRGSDGS ASIACYNGPR SFTIAGSTGA
     IDAVQQTMGS NSKFGSIKSK RLSVTNAFHS ALVDKISDGL ERIGKTLTFH RPIIPVERAT
     EMPFDMDNLD GSFVSQHMRQ PVYFNHALQR LVKRYPQAIF LEAGSSSTIT IMASRAIAQS
     QASSSDAHHF QAMSITSDTA FDSLTDATMA LWKQGLRVSF WAHHAVQARD YAQLLLPPYQ
     FDTSSRHWLP MKSPLEEVKK AAAAMVAAGG DVGTGQHQQN DALQDPRLQS LWNFVEFQDG
     DNKKPRFRIN TGSDKYNRFV LSHVIAQTAP ICPGTLECDI VIEALFSLEP TWKQEGVQPV
     VRDMINHSPI CKDPSRTVYL DLTALNKKRT QWTVRIFSVD SNSSRQASET HAEASVEMRA
     PTDAAHLREF ANFERLVSHQ QCLDVLRLNL DEEGVEVLQG RNVYRAFNPI VDYGDVYRGV
     RYVVGRGNEC AGSVQLPKCH RGDTWLDVPL SDSFSQVGGI WVNLLTDLPP SDMYIATGCG
     LSMRSPTAPP RADTDVWHVY ARHSRQGDKA FMTDLFVFDP ATGQLVELML GVQYGRVAKA
     SMSMMLARMT KDESVLRTKT PSSSHPAPTV KSVPIEASVA VKASRTTKKK AKASKSKSSV
     KKDKAPSGWR DITDEVRNLV ATVSGIEASE LELDSEMADF GIDSLMGMEL GKEVETAFKC
     TLDQNEQMEA TTLRKFVACV SNALFGPNQG QSSIDEDDED DEHSEDSSNE SSSAASDEDA
     SSGLESPDTG ILTPEDEPLP LKAVAIHKAA GLAAIAPPVE SHLALSASDI LESFGEVKMT
     TDRLMHEYGV HKTEKVMLAG SNRLCAALVV EAFDELGSPL RTAAAGQVID RVPFLPQHGR
     LMQWVYEFLE RDARLIDIDV TSGQITRTHI APPRKTSHAI LQELLASDPD FAVPNRLAYY
     AGKQLAGVLS GSTDGIRVLF GSPEGRELTA AMYCEHTFNC MSYAQMREVT KILADRIQSS
     SGSSGETFKV LEMGAGTGGT TLVMAPLLAS LSDMGMAVEY TFTDISPSMV ANARRRFSKL
     YPFMRFSVHD IEKAPADELK GQHLVLASNA IHATHNLGVS LSNIHQALRP DGFLMMLEMT
     EVVPFVDLVF GLLEGWWLFD DGRSHAVVPA EHWERELHAA GFGHVDWTDG SLPENAFQKV
     IIALASGTQG PRLPKPASVP EPIPELNPKS IETRTAHAEQ LTATYSKGWA TPKLRALDAK
     SEEGQVKPSG TSRLRKVDLG AVVLVTGATG SLGSHLVQKL ADDPNVAQVV CLNRRSNSMP
     ADKRQQEALA TRGITLSPGG RAKLRILETD TSKAQLGLPP LEYSWLVEHG TDIVHNAWPM
     SGTRPVSAFE PQLQAMRNLL DLARDMACRD INPPSRVGFQ FVSSIGVVGF VGESRVTERR
     VPLSATLPSG YGEAKWVCER MLDETLHKYP RLFRPMVVRP GQISGSSTSG FWNPVEHFAF
     LVKSAQALRA WPDLDGVLQW IPVNFCAGII VDLLKIASRA DDAYPVYHID NPVGQPWKAM
     NPVLASALDI PPHAIIPFKD WISRVRRSPL PLETENPAAR LVDFLDDHFE RMSCGGLVLD
     TSKALEHSQT MATVGPVSSD VARLYVASWK KMGYLHS
//
